New study suggests vaping CBD as possible treatment for COVID-19

As the United States continues to experience massive outbreaks of COVID-19 across the country, the medical and pharmaceutical industries are working at record speeds to discover a treatment, a cure, and a vaccine.  Within the past 24-hours, the U.S. government awarded the Big Pharma companies of Pfizer and BioNTech a $1.95 billion contract which grants them the authority to mass produce billions of doses of a coronavirus vaccine once one is discovered and approved by the U.S. Food and Drug Administration (FDA). 

In theory, every American would have instant access to the vaccine once it is proved effective and secures regulatory approval.  Furthermore, the agreement dictates that the pharmaceutical companies must provide the vaccine free of charge to all Americans. 

But a vaccine is a preventative measure designed to preclude people from contracting the virus.  Vaccines do not do much good for Americans who have already tested positive for the coronavirus.   Even more concerning, the multi-stage testing protocols required for vaccine approvals can take months – if not years – to finalize.  While everyone urgently wants a vaccine, Americans also want it to be safe and to be free of any potentially negative side effects.

There is currently no known cure for COVID-19

There has been much talk in the press and from the Trump Administration that the drug remdesivir has shown tremendous promise.  However, what most Americans do not know is that this prescription medication is typically only beneficial in the most extreme COVID-19 cases.  That is, the drug has shown positive results, but only in the most severe cases where the patient is already on a respirator and in the ICU. 

So, what does the average American do when they contract the virus but are either asymptomatic or not sick enough to be admitted to the hospital?  That question is what scientists from Augusta University in Georgia are trying to answer. 

In their recently published study entitled Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA, the study’s co-authors have identified new scientific evidence that seemingly indicates that CBD oils may help reduce the lung inflammation associated with coronavirus patients. 

“Among all cannabinoids, cannabidiol (CBD) has demonstrated potent anti-inflammatory effects in a variety of pathological conditions. Therefore, it is logical to explore whether CBD can reduce the cytokine storm and treat ARDS…
“Our results suggest a potential protective role for CBD during ARDS that may extend CBD as part of the treatment of COVID-19 by reducing the cytokine storm, protecting pulmonary tissues, and re-establishing inflammatory homeostasis.”

Related Article: 5 ways that vaping CBD might improve your health

CBD, otherwise known as cannabidiol, is a hemp-based or cannabis-based liquid that has documented anti-inflammatory capabilities. A recent article published in Arthritis Today even suggests that vaping CBD is proven to be an effective alternative therapy for patients suffering with chronic arthritis. 

“Several decades ago, scientists discovered that mammals, including humans, have a pain-regulating system (the endocannabinoid system) with receptors in nervous system tissue, immune cells and bone and joint tissue.  These receptors respond to cannabinoids, a set of compounds that include endocannabinoids, which the body creates on its own; and phyto-cannabinoids, plant-based compounds found in marijuana that are very similar to endocannabinoids.”

The Augusta University study builds upon these same principles.  Its co-authors also state that because there is no known cure for COVID-19, “the need for creative and therapeutic modalities to treat this complex condition” is now more urgent than ever. 

Related Article:   Research shows arthritis suffers turning to vaping CBD, cannabis for pain relief

(Images courtesy of Shutterstock)

Leave a comment

Please note, comments must be approved before they are published